Overhydration Negatively Affects Quality of Life in Peritoneal Dialysis Patients: Evidence from a Prospective Observational Study by ���������
Int. J. Med. Sci. 2016, Vol. 13 
 
 
http://www.medsci.org 
686 
International Journal of Medical Sciences 
2016; 13(9): 686-695. doi: 10.7150/ijms.16372 
Research Paper 
Overhydration Negatively Affects Quality of Life in 
Peritoneal Dialysis Patients: Evidence from a Prospective 
Observational Study 
Hye Eun Yoon1, Young Joo Kwon2, Ho Cheol Song3, Jin Kuk Kim4, Young Rim Song5, Seok Joon Shin1, 
Hyung Wook Kim6, Chang Hwa Lee7, Tae Won Lee8, Young Ok Kim9, Byung Soo Kim10, Kyoung Hyoub 
Moon11, Yoon Kyung Chang12, Seong Suk Kim13, Kitae Bang14, Jong Tae Cho15, Sung Ro Yun16, Ki Ryang 
Na17, Yang Wook Kim18, Byoung Geun Han19, Jong Hoon Chung20, Kwang Young Lee21, Jong Hyeok 
Jeong22, Eun Ah Hwang23, Yong-Soo Kim24, the Quality of Life of Dialysis Patients (QOLD) Study Group 
1. Department of Internal Medicine, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea;  
2. Department of Internal Medicine, Guro Hospital, Korea University;  
3. Department of Internal Medicine, Bucheon St. Mary’s Hospital, The Catholic University of Korea;  
4. Department of Internal Medicine, Soonchunhyang University Bucheon Hospital;  
5. Department of Internal Medicine, Hallym University Sacred Heart Hospital;  
6. Department of Internal Medicine, St. Vincent’s Hospital, The Catholic University of Korea;  
7. Department of Internal Medicine, Hanyang University Medical Center;  
8. Department of Internal Medicine, KyungHee University Medical Center;  
9. Department of Internal Medicine, Uijeongbu St. Mary’s Hospital, The Catholic University of Korea;  
10. Department of Internal Medicine, St. Paul’s Hospital, The Catholic University of Korea;  
11. Department of Internal Medicine, Veterans Health Service Medical Center;  
12. Department of Internal Medicine, Daejeon St. Mary’s Hospital, The Catholic University of Korea;  
13. Department of Internal Medicine, Daejeon Sun Hospital;  
14. Department of Internal Medicine, Eulji University Hospital;  
15. Department of Internal Medicine, Dankook University Hospital;  
16. Department of Internal Medicine, Konyang University Hospital;  
17. Department of Internal Medicine, Chungnam National University Hospital;  
18. Department of Internal Medicine, Inje University Haeundae Paik Hospital;  
19. Department of Internal Medicine, Yonsei University Wonju College of Medicine;  
20. Department of Internal Medicine, Chosun University Hospital;  
21. Department of Internal Medicine, Presbyterian Medical Center;  
22. Department of Internal Medicine, St. Carollo Hospital;  
23. Department of Internal Medicine, Keimyung University Dongsan Medical Center;  
24. Department of Internal Medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea  
 Corresponding author: Yong-Soo Kim, MD, PhD. Department of Internal medicine, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, 222, 
Banpo-daero, Seocho-gu, Seoul, 06591, Republic of Korea. Tel: 822-2258-6036 Fax: 822-599-3589 E-mail: kimcmc@catholic.ac.kr. 
© Ivyspring International Publisher. Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. See 
http://ivyspring.com/terms for terms and conditions. 
Received: 2016.06.03; Accepted: 2016.07.20; Published: 2016.08.11 
Abstract 
Backgound: This study evaluated whether the hydration status affected health-related quality of 
life (HRQOL) during 12 months in peritoneal dialysis (PD) patients.  
Methods: The hydration status and the HRQOL were examined at baseline and after 12 months 
using a bioimpedance spectroscopy and Kidney Disease Quality of Life-Short Form, respectively in 
PD patients. Four hundred eighty-one patients were included and divided according to the baseline 
overhydration (OH) value; normohydration group (NH group, -2L≤ OH ≤+2L, n=266) and 
overhydration group (OH group, OH >+2L, n=215). Baseline HRQOL scores were compared 
between the two groups. The subjects were re-stratified into quartiles according to the OH 
difference (OH value at baseline – OH value at 12 months; <-1, -1 – -0.1, -0.1 – +1, and ≥+1L). The 
relations of OH difference with HRQOL scores at 12 months and the association of OH difference 
with the HRQOL score difference (HRQOL score at baseline – HRQOL score at 12 months) 
were assessed.  
Results: The OH group showed significantly lower baseline physical and mental health scores 
(PCS and MCS), and kidney disease component scores (KDCS) compared with the NH group (all, 
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P<0.01). At 12 months, the adjusted PCS, MCS, and KDCS significantly increased as the OH 
difference quartiles increased (P<0.001, P=0.002, P<0.001, respectively). In multivariate analysis, 
the OH difference was independently associated with higher PCS (β = 2.04, P< .001), MCS 
(β=1.02, P=0.002), and KDCS (β=1.06, P<0.001) at 12 months. The OH difference was 
independently associated with the PCS difference (β = -1.81, P<0.001), MCS difference (β=-0.92, 
P=0.01), and KDCS difference (β=-0.90, P=0.001).  
Conclusion: The hydration status was associated with HRQOL and increased hydration status 
negatively affected HRQOL after 12 months in PD patients. 
Key words: bioimpedance, fluid overload, overhydration, peritoneal dialysis, quality of life. 
Introduction 
Euvolemia is a predictor of outcome in 
peritoneal dialysis (PD) patients [1, 2]. It is because 
volume overload is related with cardiac dysfunction 
[3, 4], arterial stiffness [5] and inflammation [6]. 
Although achievement of euvolemia is crucial in 
dialysis patients, assessment of volume status is 
relatively crude in clinical practice. Bioimpedance 
spectroscopy (BIS) measures conductance and 
reactance at different frequencies by measuring the 
flow of electrical current through the body, and 
allows accurate measurement of fluid status [7]. 
Different indices of hydration status are provided by 
the BIS, including extracellular water (ECW), 
intracellular water (ICW), total body water (TBW), 
and overhydration (OH). The ECW/TBW is most 
widely accepted as a hydration index, however it can 
be confounded by obesity [8], and it does not give the 
degree of tissue hydration. By contrast, the OH data 
provides an estimate of hydration in liters allowing 
the clinician to easily set a target weight for the 
patient without calculating an index [1]. Recently it 
was reported that the OH value was an independent 
predictor of death in PD patients [1]. 
Health-related quality of life (HRQOL) is a 
predictor of mortality in end-stage renal disease 
(ESRD) patients [9, 10]. Multiple factors are known to 
affect HRQOL in ESRD patients, including underlying 
disease, nutrition, inflammation, adverse effects of 
treatment modality, social support and rapport with 
care providers [10-14]. Recent literature showed that 
body composition is associated with HRQOL in 
hemodialysis patients [15]. It was also reported that 
hydration status is related with HRQOL in elderly 
dialysis patients, which included a relatively small 
number of patients [16]. However, whether the 
hydration status affects HRQOL has not been 
evaluated in a large number of dialysis patients in a 
prospective manner.  
The Quality of Life of Dialysis (QOLD) study 
was designed to analyze the change in HRQOL, 
depressive symptoms, and body composition of 
dialysis patients in Korea. In this prospective, 
observational multi-center study, 708 PD patients 
were recruited from 24 centers in Korea. In the current 
analyses, we analyzed 481 PD patients who were 
eligible for both the hydration status and HRQOL 
data at baseline and after 12 months to examine the 
hypothesis that hypervolemia is associated with 
worse HRQOL in PD patients.  
Methods  
Study population  
We studied PD patients who participated in the 
QOLD study. The QOLD study is a prospective, 
observational multi-center study to analyze the 
change in HRQOL, depressive symptoms, and body 
composition of dialysis patients in Korea. Inclusion 
criteria were age ≥18 years and incident or prevalent 
dialysis patients. Exclusion criteria were those who 
had psychiatric disease, current malignancy or liver 
cirrhosis, who were bed-ridden, or who cannot 
undergo bioimpedance analysis because of 
defibrillators, artificial joints, pins or limb 
amputations. The study visits were conducted at each 
center at baseline and 12 months by study 
coordinators. At each visit (baseline and after 12 
months), HRQOL, depressive symptoms, and body 
composition were assessed. Seven hundred eight PD 
patients were recruited from 24 centers in Korea. 
In the current analyses, 481 PD patients, who 
were eligible for both the hydration status and 
HRQOL data at baseline and after 12 months, were 
included. As shown in Figure 1, 634 patients were 
eligible for the baseline OH value. We used the 
baseline OH value to classify the hydration status of 
the patients. The overhydration group (OH group) 
was defined according to a previous study which 
showed that 2.0 liters was a reasonable cutoff value 
for OH in PD patients (OH >+2L) [17]. 
Normohydration group (NH group) was defined as 
patients with baseline OH value between ±2L (-2L≤ 
OH ≤+2L). Six patients who were in an 
underhydration status (OH <-2L) were excluded from 
the current analysis as this study was to compare the 
OH group and NH group. Additionally, 111 patients 
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who were lost for follow-up data, 33 patients who 
died during the study period and 3 patients who 
received renal transplantation were excluded. Among 
481 patients included in this study, 266 patients were 
in the NH group and 215 patients were in the OH 
group at baseline.  
The subjects were additionally stratified into 
quartiles according to the change in the OH value 
during 12 months. The change in the OH value was 
defined as the OH difference, which is the difference 
between the baseline OH value and that at 12 months 
(OH difference = OH value at baseline – OH value at 
12 months). The OH difference quartiles were; 
quartile 1 (OH difference <-1L, n = 120), quartile 2 (-1L
≤ OH difference <-0.1L, n = 120), quartile 3 (-0.1L≤ 
OH difference <+1L, n = 121), and quartile 4 (OH 
difference ≥+1L, n = 120).  
Instruments  
HRQOL was examined using the Korean version 
of Kidney Disease Quality of Life-Short Form 
(KDQOL-SF) [18] at baseline and at 12 months. The 
KDQOL-SF includes 36 items derived from a generic, 
validated instrument (SF-36) as well as 43 kidney 
disease-targeted items and one overall health-rating 
item. This instrument has been validated in the ESRD 
population [19]. The SF-36 domain includes subscales 
of physical functioning, role-physical, bodily pain, 
general health, emotional well-being, role-emotional, 
social function, and vitality. The kidney 
disease-targeted items include subscales of 
symptom/problem list, effects of kidney disease, 
burden of kidney disease, work status, cognitive 
function, quality of social interaction, sexual function, 
sleep, social support, dialysis staff encouragement, 
and patient satisfaction to staff. Responses to the 
KDQOL-SF were used to determine the physical 
health component scores (PCS), mental health 
component scores (MCS), and kidney disease 
component scores (KDCS). The change in each 
component score of KDQOL-SF was defined as the 
HRQOL score difference, which is the difference 
between the baseline score and score at 12 months 
(PCS difference = PCS at baseline – PCS at 12 months; 
MCS difference = MCS at baseline – MCS at 12 
months; KDCS difference = KDCS at baseline – KDCS 
at 12 months). 
 
 
Figure 1. Patient population included in this study.  
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Measurements of hydration status and body 
composition  
The hydration status and body composition 
were assessed at baseline and after 12 months. The BIS 
device (Body Composition Monitor, Fresenius 
Medical Care, Germany) was used to measure 
bioimpedance at 50 frequencies between 5 and 1000 
kHz. The measurement was performed by placing 
electrodes on one hand and one foot in the BIS device 
and entering current height and weight data into the 
machine. BIS measurements were performed with the 
peritoneal dialysate in situ, and were performed by 
one reference PD physician or nurse in each center. 
ECW, ICW, TBW, and OH were determined from the 
measured impedance data. The OH/ECW was 
calculated as the percentage of OH to ECW. The lean 
tissue index (LTI) was calculated as the quotient of 
lean tissue mass/height2 (kg/m2). The adipose tissue 
index (ATI) was calculated as the quotient of adipose 
tissue mass/height2 (kg/m2).  
Other variables 
Patients’ comorbid status was quantified using 
the modified Charlson Comorbidity Index (CCI) [20]. 
Blood pressure was recorded as the mean of two 
consecutive measurements with 5 minutes’ interval, 
using one single calibrated device in each center. 
Height and weight were measured using one single 
calibrated device in each center. Body mass index 
(BMI) was calculated as the quotient of 
weight/height2 (kg/m2). Peritoneal membrane 
characteristics were determined based on the results 
of the peritoneal equilibration test (PET) at the time of 
body composition measurements. Dialysis adequacy 
(total KT/Vurea per week), mean of renal urea and 
creatinine clearance (renal CrCl), 24-h urine volume, 
ratio of dialysate to serum creatinine at 4-h PET (D/P 
Cr), and laboratory values were collected. Dietary 
protein intake was estimated from the normalized 
protein equivalent of nitrogen appearance (nPNA) 
following the equation: PNA=15.1 + 0.1945 urea 
appearance (mM/24 h) + protein losses (g/24 h) [21].  
Statistical analysis  
Continuous data are expressed as the mean ± 
standard deviation (SD) or the median (range). 
Categorical variables are expressed as percentage of 
total. The normality of the distribution was assessed 
by the Shapiro-Wilk test. Differences between the NH 
group and the OH group were determined using 
Student’s t-test for variables with normal distribution 
or Wilcoxon rank-sum test for variables with 
non-normal distribution. Categorical variables were 
compared using a chi-square test or Fisher's exact test. 
Pearson’s correlation analysis was used to determine 
the correlation between the OH difference and the 
HRQOL scores at 12 months. Analysis of covariance 
was used to compare differences in the HRQOL scores 
at 12 months between the OH difference quartiles. 
Linear regression test was used to determine the 
association of OH difference with the HRQOL scores 
at 12 months and the HRQOL score difference. 
Multivariate models included the significantly 
associated parameters according to their weight on 
univariate testing and clinically fundamental 
parameters. A P value of < 0.05 was considered to 
indicate a statistically significant difference and 
statistical analysis was performed using SAS. 
Ethics statement and trial registration  
All participants gave written informed consent, 
and the study protocol was approved by the 
following institutional review boards of the centers 
participated in the study: Korea University Guro 
Hospital, Catholic University of Korea Bucheon St. 
Mary’s Hospital, Incheon St. Mary’s Hospital, St. 
Vincent’s Hospital, St. Paul’s Hospital, Uijeongbu St. 
Mary’s Hospital, Daejeon St. Mary’s Hospital and 
Seoul St. Mary’s Hospital, Soonchunhyang University 
Hospital, Hallym University Medical Center, 
Hanyang University Medical Center, KyungHee 
University Medical Center, Veterans Health Service 
Medical Center, Daejeon Sun Hospital, Eulji 
University Hospital, Dankook University Hospital, 
Konyang University Hospital, Chungnam National 
University Hospital, Inje University Haeundae Paik 
Hospital, Wonju Severance Christian Hospital, 
Chosun University Hospital, Presbyterian Medical 
Center, St. Carollo Hospital, and Keimyung 
University Dongsan Medical Center. The study was 
conducted from August 2010 to May 2014.  
The study was registered at clinicaltrials.gov 
(NCT01668628), and was conducted in adherence to 
the Declaration of Helsinki. The authors confirm that 
all onging and related trials for this intervention have 
been registered. There was a delay in registering this 
study because centers were additionally recruited to 
participate in this study. 
Results  
Baseline characteristics 
Table 1 shows the baseline characteristics and 
laboratory and bioimpedance measurements of the 
total patients and the comparison between the NH 
group and OH group. More male, diabetes, and 
continuous ambulatory PD patients were in the OH 
group than the NH group. The OH group showed 
higher CCI, total drained dialysate volume, and 
systolic blood pressure compared to the NH group. 
The OH group had higher D/P Cr and more patients 
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with high average or high membrane transporter 
types than the NH group. The OH group consisted of 
less patients using 1.5% glucose bags only and more 
patients using 2.5% glucose bag at least once a day. 
The nPNA values were significantly lower in the OH 
group compared to the NH group.  
At baseline, the OH group showed lower 
haemoglobin and albumin levels than the NH group. 
As expected, the OH group showed higher TBW, 
ECW, ICW, OH, OH/ECW values than the NH 
group. The ATI was significantly lower in the OH 
group compared to the NH group, but there was no 
difference in the LTI.  
 
Table 1. Baseline characteristics and laboratory and bioimpedance measurements. 
  Total patients in the 
current analysis 
NH group OH group P 
n = 481 n = 266 n = 215 
Age 51.3 ± 11.1 50.9 ± 11.6 51.8 ± 10.4 0.38 
Male (%) 256 (53.2) 117 (44) 139 (64.7) <0.001 
Dialysis vintage (mo) 23.6 ± 34.1 25.1 ± 34.7 21.6 ± 33.3 0.27 
Diabetes (%) 208 (43.2) 75 (28.2) 133 (61.9) <0.001 
Cause of ESRD (%)    <0.001 
Diabetes 198 (41.2) 67 (25.2) 131 (60.9)  
Hypertension 179 (37.2) 124 (46.6) 55 (25.6)  
Glomerulonephritis 52 (10.8) 37 (13.9) 15 (7)  
Others 52 (10.8) 38 (14.3) 14 (6.5)  
CCI 2.6 ± 1.0 2.4 ± 0.9 2.8 ± 1.1 <0.001 
BMI (kg/m2) 24.2 ± 3.5 24.2 ± 3.7 24.2 ± 3.3 0.96 
Systolic blood pressure (mmHg) 132.2 ± 21.8 128.8 ± 19.1 136.4 ± 24.2 <0.001 
Diastolic blood pressure (mmHg) 80.7 ± 12.7 79.7 ± 12.5 81.9 ± 12.9 0.05 
Peritoneal dialysis modality (%)    <0.001 
CAPD 424 (88.1) 222 (83.5) 202 (94)  
APD 57 (11.9) 44 (16.5) 13 (6.1)  
D/P Cr at 4-h PET 0.60 ± 0.11 0.59 ± 0.12 0.62 ± 0.11 0.005 
Type of membrane transport (%)    0.007 
Low 82 (17.0) 59 (22.2) 23 (10.7)  
Low average 232 (48.2) 125 (47) 107 (49.8)  
High average 148 (30.8) 72 (27.1) 76 (35.4)  
High 19 (4.0) 10 (3.8) 9 (4.2)  
Total drained dialysate volume (mL/day) 8469.3 ± 1328.0 8336.0 ± 1370.4 8637.4 ± 1255.6 0.01 
Dialysate usage (%)     
1.5% glucose bags only 205 (42.6) 126 (47.4) 79 (36.7) 0.02 
2.5% glucose bag at least once 253 (52.6) 127 (47.7) 126 (58.6) 0.02 
4.25% glucose bag at least once 33 (6.9) 15 (5.6) 18 (8.4) 0.24 
Icodextrin bag usage 18 (3.7) 9 (3.4) 9 (4.2) 0.64 
24-h urine volume (mL/day) 763.9 ± 555.5 741.3 ± 540.6 793.6 ± 574.8 0.35 
Renal CrCl (mL/min/1.73m2) 3.55 (0, 163.4) 3.6 (0, 163.4) 3.4(0, 74.3) 0.67 
Total KT/Vurea per week 2.4 ± 1.1 2.5 ± 1.1 2.3 ± 1.0 0.06 
nPNA (g/kg/day) 0.58 ± 0.26 0.6 ± 0.3 0.5 ± 0.2 0.003 
Laboratory measurements     
Haemoglobin (g/dL) 10.7 ± 1.4 10.8 ± 1.3 10.5 ± 1.4 0.003 
Creatinine (mg/dL) 9.6 ± 3.7 9.8 ± 3.7 9.4 ± 3.7 0.24 
Sodium (mEq/L) 138.8 ± 3.4 139 ± 3.4 138.6 ± 3.4 0.22 
Potassium (mEq/L) 4.5 ± 1.6 4.4 ±0.8 4.5 ± 2.2 0.53 
Albumin (g/dL) 3.6 ± 0.5 3.8 ± 0.4 3.4 ± 0.5 <0.001 
Total cholesterol (g/dL) 176.3 ± 42.6 179.6 ± 42.0 172.1 ± 43.0 0.06 
C-reactive protein (g/dL) 0.2 (0, 61.2) 0.2 (0, 61.2) 0.2 (0, 18.8) 0.06 
Bioimpedance measurements     
TBW (L) 34.5 ± 7.1 32.7 ± 6.8 36.7 ± 6.8 <0.001 
ECW (L) 16.3 ± 3.5 14.8 ± 2.8 18.2 ± 3.2 <0.001 
ICW (L) 18.2 ± 4.1 17.9 ± 4.1 18.5 ± 4 0.13 
OH (L) 2.2 ± 2.1 0.8 (-1.8, 2) 3.5 (2.1, 9.6) <0.001 
OH/ECW (%) 12.2 ± 10.7 4.5 ± 6.2 21.7 ± 6.9 <0.001 
LTI (kg/m2)  14.4 ± 3.1 14.3 ± 3.1 14.4 ± 3.1 0.86 
ATI (kg/m2) 8.8 ± 4.1 9.4 ± 4.3 8.1 ± 3.7 <0.001 
Values expressed with a plus/minus sign are the mean ± SD. Values expressed with a parentheses are the median (range).  
NH group, normohydration group; OH group, overhydration group; ESRD, end-stage renal disease; CCI, Charlson comorbidity index; BMI, body mass index; CAPD, continuous 
ambulatory peritoneal dialysis; APD, automated peritoneal dialysis; D/P Cr at 4-h PET, the ratio of dialysate creatinine to plasma creatinine at 4-h peritoneal equilibration test; CrCl, 
creatinine clearance; nPNA, normalized protein equilvalent of nitrogen appearance; TBW, total body water; ECW, extracellular water; ICW, intracellular water; OH, overhydration; 
OH/ECW, the ratio of overhydration to extracellular water; LTI, lean tissue index; ATI, adipose tissue index. 
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HRQOL scores at baseline  
Each component score of KDQOL-SF at baseline 
was compared between the two groups. The average 
of PCS, MCS, and KDCS at baseline were significantly 
lower in the OH group compared with the NH group 
(NH vs. OH; PCS, 55.5 ± 16.2 vs. 51.5 ± 16.5, P = 0.008; 
MCS, 50.1 ± 10.6 vs. 47.5 ± 11.1, P = 0.009; KDCS, 69.3 
± 9.6 vs. 67.0 ± 9.6, P = 0.008; Fig 2). 
The subscales of the KDQOL-SF at baseline were 
compared (Table 2). Among the SF-36 domains, the 
OH group showed significantly lower scores in 
physical functioning, bodily pain, general health, and 
social function. Among the kidney disease-specific 
domains, the OH group showed significantly lower 
scores in effects of kidney disease, burden of kidney 
disease, and cognitive function.  
 
 
 
Figure 2. The HRQOL scores at baseline according to the hydration 
status. The average scores of PCS, MCS, and KDCS at baseline were 
significantly lower in the OH group compared with the NH group.  
 
Correlations between the OH difference and 
the HRQOL scores at 12 months  
Table 3 shows the correlation coefficients 
between the OH difference and subscales of the 
KDQOL-SF at 12 months. In unadjusted analysis, the 
OH difference showed positive correlations with 
scores of bodily pain and patient satisfaction. After 
adjustment for the baseline OH value, the OH 
difference showed significant positive correlations 
with scores of physical functioning, role-physical, 
bodily pain, general health, role-emotional, and social 
function in the SF-36 domains. In the kidney 
disease-specific domains, the OH difference showed 
significant positive correlations with scores of 
symptom problem list, effect of kidney disease, 
burden of kidney disease, cognitive function, sleep, 
social support and patient satisfaction after 
adjustment for the baseline OH value.  
 
 
Table 2. Baseline HRQOL scores. 
  Total patients (n 
= 481) 
NH group (n = 
266) 
OH group (n 
= 215) 
P 
SF-36 domains        
Physical functioning 73.1 ± 22.4 75.3 ± 21.5 70.4±23.2 0.02 
Role-physical 50 (0, 100) 50 (0, 100) 50(0,100) 0.33 
Bodily pain 76.5 ± 22.9 79 ± 20.5 73.5±25.3 0.01 
General health  39.9 ± 21.7 42.8 ± 21.1 36.4±22.1 0.001 
Emotional well-being 30.2 ± 14.8 29.7 ± 13.8 30.9±16 0.39 
Role-emotional 74.5 ± 24.5 75.7 ± 22.5 73±26.8 0.25 
Social function 69.6 ± 25.0 72.1 ± 24.5 66.5±25.2 0.01 
Vitality 30.3 ± 14.3 30.2 ± 14.2 30.5±14.5 0.78 
Kidney disease-specific domains 
Symptom problem list 79.2 ± 15.6 80.3 ± 14.7 77.8 ± 16.7 0.08 
Effect of kidney 
disease 
75.6 ± 16.2 77.3 ± 16.1 73.5 ± 16.2 0.01 
Burden of kidney 
disease 
36.4 ± 25.3 38.7 ± 25.9 33.5 ± 24.2 0.03 
Work status 47.9 ± 25.3 47.6 ± 25 48.4 ± 25.8 0.73 
Cognitive function 83.5 ± 15.9 85.5 ± 14.6 81.1 ± 17.1 0.004 
Quality of social 
interaction 
70.6 ± 14.4 71.0 ± 15.2 70 ± 13.3 0.45 
Sexual function  65.0 ± 32.5 68.0 ± 32.4 61.2 ± 32.3 0.13 
Sleep  69.3 ± 15.5 70.3 ± 15.6 68 ± 15.3 0.10 
Social support  65.9 ± 23.6 66.7 ± 22.3 64.9 ± 25.2 0.41 
Dialysis staff 
encouragement  
100 (0, 100) 100 (0, 100) 100 (0, 100) 0.81 
Patient satisfaction  66.7 ± 17.1 67.4 ± 21.8 65.8 ± 22.3 0.43 
Values expressed with a plus/minus sign are the mean ± SD. Values expressed with a 
parentheses are the median (range).  
NH group, normohydration group; OH group, overhydration group. 
 
 
Table 3. Correlations of the OH difference with the HRQOL 
scores at 12 months. 
  Unadjusted r P Adjusted ra P 
SF-36 domains     
Physical functioning 0.08 0.08 0.22 <0.001 
Role-physical 0.05 0.29 0.16 <0.001 
Bodily pain 0.10 0.02 0.18 <0.001 
General health  0.06 0.18 0.13 0.005 
Emotional well-being 0.08 0.10 0.02 0.61 
Role-emotional 0.08 0.08 0.13 0.006 
Social function 0.03 0.46 0.12 0.01 
Vitality 0.02 0.62 0.009 0.84 
Kidney disease-specific domains     
Symptom problem list 0.01 0.78 0.09 0.046 
Effect of kidney disease 0.05 0.30 0.15 0.001 
Burden of kidney disease 0.07 0.15 0.13 0.004 
Work status 0.03 0.58 0.02 0.71 
Cognitive function 0.07 0.14 0.13 0.003 
Quality of social interaction0 0.008 0.85 0.03 0.51 
Sexual function  -0.11 0.13 0.10 0.17 
Sleep  0.07 0.15 0.12 0.007 
Social support  0.08 0.08 0.12 0.009 
Dialysis staff encouragement  0.05 0.27 0.03 0.50 
Patient satisfaction  0.12 0.01 0.11 0.01 
aAdjusted for the baseline OH value. 
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Impact of the OH difference on the HRQOL 
scores at 12 months  
Each component score of KDQOL-SF at 12 
months was compared between the OH difference 
quartiles (Fig 3). As the OH difference quartile 
increased, there was a significant trend toward an 
increase in adjusted PCS, MCS, and KDCS at 12 
months after adjustments for age, sex, dialysis 
vintage, diabetes, haemoglobin, albumin, CCI, total 
KT/Vurea per week, renal CrCl, nPNA, 24-h urine 
volume, the baseline OH value, and each baseline 
component score (PCS, P < 0.001; MCS, P = 0.002; 
KDCS, P < 0.001). 
 
 
 
 
Figure 3. The Adjusted HRQOL scores at 12 months according to 
the OH difference quartiles. As the OH difference quartile increased, there 
was a significant trend toward an increase in scores of PCS (A), MCS (B), and 
KDCS (C) at 12 months. Adjustments were made for age, sex, dialysis vintage, 
diabetes, haemoglobin, albumin, CCI, total KT/Vurea, renal CrCl, nPNA, 24-h 
urine volume, the baseline OH value, and each component score at baseline 
(baseline PCS, MCS, and KDCS, respectively). 
 
To evaluate whether the change in hydration 
status was associated with the HRQOL scores after 12 
months, linear regression analysis was performed 
(Table 4). After adjustments for age and sex (Model 1), 
the OH difference showed significant positive 
associations with PCS (β  = 2.18, 95% confidence 
interval [CI] 1.27 – 3.09, P < 0.001), MCS (β = 1.06, 
95% CI 0.46 – 1.65, P < 0.001), and KDCS (β = 1.05, 
95% CI 0.54 – 1.56, P < 0.001) at 12 months. These 
associations remained robust after adjustments for 
dialysis vintage, diabetes, haemoglobin, albumin, 
CCI, total KT/Vurea per week, renal CrCl, nPNA, 
24-h urine volume and the baseline OH value (Model 
2; PCS, β = 2.25, 95% CI 1.23 – 3.28, P < 0.001; MCS, β 
= 1.08, 95% CI 0.40 – 1.77, P = 0.002; KDCS, β = 1.29, 
95% CI 0.71 – 1.88, P < 0.001). Moreover, these 
associations were significant after adjustments for 
baseline PCS, MCS, and KDCS, respectively (Model 3; 
PCS, β = 2.04, 95% CI 1.01 – 2.97, P < 0.001; MCS, β = 
1.02, 95% CI 0.38 – 1.65, P = 0.002; KDCS, β = 1.06, 
95% CI 0.57 – 1.55, P < 0.001).  
 
Table 4. Regression coefficients of the OH difference for the 
HRQOL scores at 12 months. 
  βa 95% CI P 
PCS at 12 months 
Model 1 2.18  1.27, 3.09  <0.001 
Model 2 2.25  1.23, 3.28  <0.001 
Model 3 2.04  1.01, 2.97  <0.001 
MCS at 12 months  
Model 1 1.06  0.46, 1.65  <0.001 
Model 2 1.08  0.40, 1.77  0.002 
Model 3 1.02  0.38, 1.65  0.002 
KDCS at 12 months  
Model 1 1.05  0.54, 1.56  <0.001 
Model 2 1.29  0.71, 1.88  <0.001 
Model 3 1.06  0.57, 1.55  <0.001 
aRegression coefficient 
Model 1: Adjusted for age and sex. 
Model 2: Adjusted for Model 1 plus dialysis vintage, diabetes, haemoglobin, albumin, CCI, 
total KT/Vurea per week, renal CrCl, nPNA, 24-h urine volume and the baseline OH 
value. 
Model 3: Adjusted for Model 2 plus baseline scores of PCS, MCS, and KDCS, respectively. 
 
 
Impact of the OH difference on the HRQOL 
score difference  
To evaluate whether the change in hydration 
status was associated with the change in HRQOL 
scores, linear regression analysis was performed 
(Table 5). After adjustments for age and sex (Model 1), 
the OH difference was significantly negatively 
associated with the PCS difference (β = -1.64, 95% CI 
-2.47– -0.80, P < 0.001), and the KDCS difference (β = 
-0.48, 95% CI -0.95 – -0.01, P = 0.04). These associations 
remained robust after adjustments for dialysis 
vintage, diabetes, haemoglobin, albumin, CCI, total 
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KT/Vurea per week, renal CrCl, nPNA, 24-h urine 
volume and the baseline OH value (Model 2; PCS 
difference, β = -1.81, 95% CI -2.84 – -0.78, P < 0.001; 
MCS difference, β = -0.92, 95% CI -1.65 – -0.20, P = 
0.01; KDCS difference, β = -0.90, 95% CI -1.44 – -0.36, 
P = 0.001). 
 
 
Table 5. Regression coefficients of the OH difference for the 
HRQOL score difference. 
  βa 95% CI P 
PCS difference (PCS at baseline - PCS at 12 months) 
Model 1 -1.64 -2.47, -0.80  <0.001 
Model 2 -1.81 -2.84, -0.78  <0.001 
MCS difference (MCS at baseline - MCS at 12 months) 
Model 1 -0.59  -1.19, 0.006 0.052 
Model 2 -0.92  -1.65, -0.20  0.01 
KDCS difference (KDCS at baseline - KDCS at 12 months) 
Model 1 -0.48 -0.95, -0.01  0.04 
Model 2 -0.90 -1.44, -0.36  0.001 
aRegression coefficient 
Model 1: Adjusted for age and sex. 
Model 2: Adjusted for Model 1 plus dialysis vintage, diabetes, haemoglobin, albumin, CCI, 
total KT/Vurea per week, renal CrCl, nPNA, 24-h urine volume and the baseline OH 
value. 
 
 
Discussion  
 The QOLD study is the first multi-center study 
of change in HRQOL, depressive symptoms, and 
body composition in PD patients. The results of the 
present study show that the baseline hydration status 
was associated with the baseline HRQOL scores and 
that the change in hydration status was related with 
the HRQOL scores after 12 months and the change in 
HRQOL scores in PD patients. The associations were 
significant after adjusting multiple factors including 
nutrition, anemia, residual renal function, dialysis 
adequacy, as well as the baseline hydration status and 
baseline HRQOL scores. These findings implicate that 
interventions to achieve euvolemia may potentially 
improve the HRQOL in PD patients.  
HRQOL is a powerful predictor of mortality in 
ESRD patients [9, 10]. Euvolemia is also a predictor of 
mortality in PD patients [1, 2]. However, monitoring 
of HRQOL is not routinely done and accurate 
assessment of volume status is relatively crude in 
clinical practice. The novelty of this study is that we 
demonstrated that the hydration status was 
associated with HRQOL, not only at baseline, but also 
after 12 months. At baseline, the OH group showed 
better baseline PCS, MCS, and KDCS compared to the 
NH group. We speculate several reasons for this 
association. First, the OH group was more anemic 
than the NH group. A previous systematic review 
demonstrated that hematocrit level showed a 
consistent relationship with HRQOL in ESRD patients 
[22]. Second, the OH group was more 
hypoalbuminemic than the NH group. Nutritional 
biomarkers including albumin are well known 
predictors of both generic and disease-specific 
HRQOL in ESRD patients [22]. Third, the OH group 
was more diabetic and had multimorbidity, both of 
which were shown to be negatively associated with 
HRQOL in ESRD patients [23-25]. After 12 months, 
the OH difference showed positive correlations with 
most of the subscales of the KDQOL-SF, after 
adjustment for the baseline OH value. This suggested 
that the decrease in hydration status (positive OH 
difference) was associated better HRQOL scores after 
12 months. To strengthen the statistical power, we 
stratified the patients into quartiles according to the 
OH difference. The adjusted PCS, MCS, and KDCS 
after 12 months significantly increased as the OH 
difference quartiles increased. In regression analysis, 
the decrease in hydration status (positive OH 
difference) was independently associated with better 
PCS, MCS, KDCS after adjustments for multiple 
variables including the baseline OH value and 
baseline component score of KDQOL-SF. Moreover, 
the decrease in hydration status (positive OH 
difference) was independently associated with 
improvement in PCS, MCS, KDCS (negative PCS, 
MCS, and KDCS difference). These findings suggest 
that decrease in hydration status is associated with 
improvement in HRQOL score after 12 months. 
Interestingly, the OH difference was more strongly 
associated with PCS difference than it did with MCS 
difference or KDCS difference. As physical function is 
closely related with muscle mass and cardiac 
function, several mechanisms can be postulated. First, 
the increase in hydration status may reflect 
progressive muscle loss and malnutrition [26]. 
Second, the increase in hydration status may be 
related to cardiac injury. It was reported that there is a 
longitudinal correlation between ECW and brain 
natriuretic peptide [27], which is strongly related with 
cardiac abnormalities in PD patients [28].  
Hypervolemia was a frequent finding in our 
patients. Among 481 patients included in this study, 
44.7% of patients were overhydrated. This finding is 
similar to that from a multi-center European study of 
639 PD patients, which showed that 53.4% of patients 
were overhydrated and 24% had OH values 
equivalent to >2L [29]. In this study, all hydration 
indices were higher in the OH group than the NH 
group. The total drained dialysate volume was also 
higher and more patients used 2.5% glucose 
dialysates at least once in the OH group. However, 
the use of 4.25% glucose dialysate or icodextrin was 
not different. Although the OH group showed higher 
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peritoneal transport characteristics, the proportion of 
automated PD was lower and the use of icodextrin 
was not different compared with the NH group. The 
reason for this is unclear, since it was a multi-center 
study. However, these findings suggest that the PD 
prescription or fluid and salt restriction failed to 
achieve euvolemia in our study population.  
In this study, the OH group was more likely to 
be male, diabetic, and hypoalbuminemic and to have 
multiple comorbidities and higher blood pressures, 
which is consistent with previous reports [19]. The 
reason for the male predominance in the OH group is 
not clear, but a similar finding was shown in a study 
of non-dialysis dependent chronic kidney disease 
patients [30]. The relationship between hydration 
status and hypoalbuminemia was also reported 
previously [29, 31]. There may be several reasons. 
First, the low dietary protein intake may be involved, 
as the OH group demonstrated lower nPNA levels 
than the NH group. However, the LTI or the serum 
creatinine was not different between the two groups, 
suggesting that muscle mass was not different. 
Second, hypoalbuminemia per se determines tissue 
hydration. Radio labeled albumin used to determine 
plasma volume demonstrated that the excess fluid 
associated with hypoalbuminemia is due to 
extravascular rather than intravascular volume 
expansion, which results from reduced oncotic 
pressure [31]. Third, the hydration status can also be 
affected by peritoneal membrane transport 
characteristics [32]. Rapid peritoneal solute transport 
is associated with increased peritoneal protein losses, 
contributing to hypoalbuminemia [33]. Our study 
population showed higher D/P Cr and more high and 
high average transporters in the OH group, which 
supports the association between hydration status 
and hypoalbuminemia.  
There are limitations to this study. First, the 
effects of medications which may affect the hydration 
status or anemia were not analyzed. Second, data of 
dietary fluid and salt intake were lacking. Whether 
the overhydrated patients had excessive sodium and 
water intake or the prescription of PD was inadequate 
cannot be determined in this study. Third, the direct 
effect of hydration status on HRQOL could not be 
proven due to the observational manner of this study. 
Fourth, subjects with loss of data were excluded from 
the analysis.  
In conclusion, this study demonstrates that the 
hydration status negatively affects the HRQOL in PD 
patients. Interventions to control volume overload 
may improve the HRQOL in PD patients with better 
outcomes.  
Acknowledgement  
The authors want to thank Kyungdo Han 
(Department of Biostatistics, College of Medicine, The 
Catholic University of Korea) for his statistical 
analysis. 
Competing Interests  
The authors have declared that no competing 
interest exists. 
References 
1. O'Lone EL, Visser A, Finney H, Fan SL. Clinical significance of 
multi-frequency bioimpedance spectroscopy in peritoneal dialysis patients: 
independent predictor of patient survival. Nephrol Dial Transplant. 2014; 29: 
1430-7. 
2. Paniagua R, Ventura MD, Avila-Diaz M, et al. NT-proBNP, fluid volume 
overload and dialysis modality are independent predictors of mortality in 
ESRD patients. Nephrol Dial Transplant. 2010; 25: 551-7. 
3. Enia G, Mallamaci F, Benedetto FA, et al. Long-term CAPD patients are 
volume expanded and display more severe left ventricular hypertrophy than 
haemodialysis patients. Nephrol Dial Transplant. 2001; 16: 1459-64. 
4. Konings CJ, Kooman JP, Schonck M, et al. Fluid status, blood pressure, and 
cardiovascular abnormalities in patients on peritoneal dialysis. Perit Dial Int. 
2002; 22: 477-87. 
5. Hogas S, Ardeleanu S, Segall L, et al. Changes in arterial stiffness following 
dialysis in relation to overhydration and to endothelial function. Int Urol 
Nephrol. 2012; 44: 897-905. 
6. Demirci MS, Demirci C, Ozdogan O, et al. Relations between 
malnutrition-inflammation-atherosclerosis and volume status. The usefulness 
of bioimpedance analysis in peritoneal dialysis patients. Nephrol Dial 
Transplant. 2011; 26: 1708-16. 
7. Passauer J, Petrov H, Schleser A, Leicht J, Pucalka K. Evaluation of clinical dry 
weight assessment in haemodialysis patients using bioimpedance 
spectroscopy: a cross-sectional study. Nephrol Dial Transplant. 2010; 25: 
545-51. 
8. Craven JL, Rodin GM, Littlefield C. The Beck Depression Inventory as a 
screening device for major depression in renal dialysis patients. Int J 
Psychiatry Med. 1988; 18: 365-74. 
9. Cohen SD, Norris L, Acquaviva K, Peterson RA, Kimmel PL. Screening, 
diagnosis, and treatment of depression in patients with end-stage renal 
disease. Clin J Am Soc Nephrol. 2007; 2: 1332-42. 
10. Simic Ogrizovic S, Jovanovic D, Dopsaj V, et al. Could depression be a new 
branch of MIA syndrome? Clin Nephrol. 2009; 71: 164-72. 
11. Chilcot J, Davenport A, Wellsted D, Firth J, Farrington K. An association 
between depressive symptoms and survival in incident dialysis patients. 
Nephrol Dial Transplant. 2011; 26: 1628-34. 
12. Kimmel PL, Phillips TM, Simmens SJ, et al. Immunologic function and 
survival in hemodialysis patients. Kidney Int. 1998; 54: 236-44. 
13. Kimmel PL, Peterson RA, Weihs KL, et al. Multiple measurements of 
depression predict mortality in a longitudinal study of chronic hemodialysis 
outpatients. Kidney Int. 2000; 57: 2093-8. 
14. Plantinga LC, Fink NE, Harrington-Levey R, et al. Association of social 
support with outcomes in incident dialysis patients. Clin J Am Soc Nephrol. 
2010; 5: 1480-8. 
15. Martinson M, Ikizler TA, Morrell G, et al. Associations of body size and body 
composition with functional ability and quality of life in hemodialysis 
patients. Clin J Am Soc Nephrol. 2014; 9: 1082-90. 
16. Laegreid IK, Bye A, Aasarod K, Jordhoy M. Nutritional problems, 
overhydration and the association with quality of life in elderly dialysis 
patients. Int Urol Nephrol. 2012; 44: 1885-92. 
17. Luo YJ, Wang T. What is the upper limitation of volume in Chinese peritoneal 
dialysis patients? Blood Purif. 2011; 31: 289-95. 
18. Park HJ, Kim S, Yong JS, et al. Reliability and validity of the Korean version of 
Kidney Disease Quality of Life instrument (KDQOL-SF). Tohoku J Exp Med. 
2007; 211: 321-9. 
19. Korevaar JC, Merkus MP, Jansen MA, Dekker FW, Boeschoten EW, Krediet 
RT. Validation of the KDQOL-SF: a dialysis-targeted health measure. Qual 
Life Res. 2002; 11: 437-47. 
20. Hemmelgarn BR, Manns BJ, Quan H, Ghali WA. Adapting the Charlson 
Comorbidity Index for use in patients with ESRD. Am J Kidney Dis. 2003; 42: 
125-32. 
21. Bergstrom J, Heimburger O, Lindholm B. Calculation of the protein equivalent 
of total nitrogen appearance from urea appearance. Which formulas should be 
used? Perit Dial Int. 1998; 18: 467-73. 
22. Spiegel BM, Melmed G, Robbins S, Esrailian E. Biomarkers and health-related 
quality of life in end-stage renal disease: a systematic review. Clin J Am Soc 
Nephrol. 2008; 3: 1759-68. 
Int. J. Med. Sci. 2016, Vol. 13 
 
http://www.medsci.org 
695 
23. Md Yusop NB, Yoke Mun C, Shariff ZM, Beng Huat C. Factors associated with 
quality of life among hemodialysis patients in Malaysia. PLoS One. 2013; 8: 
e84152. 
24. Sorensen VR, Mathiesen ER, Watt T, Bjorner JB, Andersen MV, 
Feldt-Rasmussen B. Diabetic patients treated with dialysis: complications and 
quality of life. Diabetologia. 2007; 50: 2254-62. 
25. Park HC, Yoon HB, Son MJ, et al. Depression and health-related quality of life 
in maintenance hemodialysis patients. Clin Nephrol. 2010; 73: 374-80. 
26. Davies SJ, Davenport A. The role of bioimpedance and biomarkers in helping 
to aid clinical decision-making of volume assessments in dialysis patients. 
Kidney Int. 2014. 
27. Davenport A. Changes in N-terminal pro-brain natriuretic peptide correlate 
with fluid volume changes assessed by bioimpedance in peritoneal dialysis 
patients. Am J Nephrol. 2012; 36: 371-6. 
28. Wang AY, Lam CW, Wang M, et al. Diagnostic potential of serum biomarkers 
for left ventricular abnormalities in chronic peritoneal dialysis patients. 
Nephrol Dial Transplant. 2009; 24: 1962-9. 
29. Van Biesen W, Williams JD, Covic AC, et al. Fluid status in peritoneal dialysis 
patients: the European Body Composition Monitoring (EuroBCM) study 
cohort. PLoS One. 2011; 6: e17148. 
30. Hung SC, Kuo KL, Peng CH, et al. Volume overload correlates with 
cardiovascular risk factors in patients with chronic kidney disease. Kidney Int. 
2014; 85: 703-9. 
31. John B, Tan BK, Dainty S, Spanel P, Smith D, Davies SJ. Plasma volume, 
albumin, and fluid status in peritoneal dialysis patients. Clin J Am Soc 
Nephrol. 2010; 5: 1463-70. 
32. Konings CJ, Kooman JP, Schonck M, et al. Fluid status in CAPD patients is 
related to peritoneal transport and residual renal function: evidence from a 
longitudinal study. Nephrol Dial Transplant. 2003; 18: 797-803. 
33. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D. 
Increased peritoneal membrane transport is associated with decreased patient 
and technique survival for continuous peritoneal dialysis patients. The 
Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol. 
1998; 9: 1285-92. 
